Cornea/External Disease News

Bausch + Lomb has launched Blink NutriTears, an over-the-counter supplement designed to target the root causes of dry eye disease and promote healthy tear production, the company announced in a press release.

Azura Ophthalmics announced that the first patient has been enrolled in the phase 3 ASTRO study of AZR-MD-001 for patients with clinical signs and symptoms of meibomian gland dysfunction.

Vevye, a nonpreserved cyclosporine 0.1% ophthalmic solution, demonstrated sustained safety and efficacy among patients with dry eye disease, according to 52-week ESSENCE-2 open-label extension study results published in Cornea.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Roger Kennedy, director of marketing for BioTissue, announces the launch of the CAM360 AmnioGraft.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Eric D. Donnenfeld, MD, discusses Lacrifill for the management of dry eye disease.

Catch up on the top Healio Video Perspectives from this year’s Association for Research in Vision and Ophthalmology meeting.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Preeya K. Gupta, MD, discusses Vevye’s positive impact on the signs and symptoms of dry eye disease.

Ophthalmologists must work with oncologists to understand and mitigate ocular surface adverse events caused by oncologic therapeutics, according to a presentation at Real World Ophthalmology.

Ever heard of a helical collagen intercalator? How about a TRPM8 agonist? Maybe RASP as a target of treatment?

When a young patient presents with atypical refractive findings and an inability to see 20/20 in one eye, that eye is often labeled “amblyopic.”